Home Other Building Blocks 2-Amino-3-(1-methyl-1H-indol-3-yl)propanoic acid

2-Amino-3-(1-methyl-1H-indol-3-yl)propanoic acid

CAS No.:
26988-72-7
Catalog Number:
AG0037GK
Molecular Formula:
C12H14N2O2
Molecular Weight:
218.2518
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
1 week
United States
$467
- +
5g
1 week
United States
$1992
- +
10g
1 week
United States
$3627
- +
Product Description
Catalog Number:
AG0037GK
Chemical Name:
2-Amino-3-(1-methyl-1H-indol-3-yl)propanoic acid
CAS Number:
26988-72-7
Molecular Formula:
C12H14N2O2
Molecular Weight:
218.2518
MDL Number:
MFCD00005803
IUPAC Name:
2-amino-3-(1-methylindol-3-yl)propanoic acid
InChI:
InChI=1S/C12H14N2O2/c1-14-7-8(6-10(13)12(15)16)9-4-2-3-5-11(9)14/h2-5,7,10H,6,13H2,1H3,(H,15,16)
InChI Key:
ZADWXFSZEAPBJS-UHFFFAOYSA-N
SMILES:
OC(=O)C(Cc1cn(c2c1cccc2)C)N
EC Number:
248-157-6
Properties
Complexity:
270  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
218.106g/mol
Formal Charge:
0
Heavy Atom Count:
16  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
218.256g/mol
Monoisotopic Mass:
218.106g/mol
Rotatable Bond Count:
3  
Topological Polar Surface Area:
68.2A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
XLogP3:
-1.3  
Literature
Title Journal
Indoleamine 2,3-dioxygenase mediates anhedonia and anxiety-like behaviors caused by peripheral lipopolysaccharide immune challenge. Hormones and behavior 20120801
Addition of an indoleamine 2,3,-dioxygenase inhibitor to B cell-depletion therapy blocks autoreactive B cell activation and recurrence of arthritis in K/BxN mice. Arthritis and rheumatism 20120701
Induction of prolonged asthma tolerance by IL-10-differentiated dendritic cells: differential impact on airway hyperresponsiveness and the Th2 immunoinflammatory response. Journal of immunology (Baltimore, Md. : 1950) 20120701
Effects of indoleamine 2,3-dioxygenases in carbon tetrachloride-induced hepatitis model of rats. Cell biochemistry and function 20120601
Suppression of azoxymethane-induced colonic preneoplastic lesions in rats by 1-methyltryptophan, an inhibitor of indoleamine 2,3-dioxygenase. Cancer science 20120501
Novel Cβ-Cγ bond cleavages of tryptophan-containing peptide radical cations. Journal of the American Society for Mass Spectrometry 20120201
Activated CD69+ T cells foster immune privilege by regulating IDO expression in tumor-associated macrophages. Journal of immunology (Baltimore, Md. : 1950) 20120201
IDO and regulatory T cell support are critical for cytotoxic T lymphocyte-associated Ag-4 Ig-mediated long-term solid organ allograft survival. Journal of immunology (Baltimore, Md. : 1950) 20120101
The indoleamine 2,3-dioxygenase inhibitor 1-methyl-tryptophan suppresses mitochondrial function, induces aerobic glycolysis and decreases interleukin-10 production in human lymphocytes. Immunological investigations 20120101
M. tuberculosis induces potent activation of IDO-1, but this is not essential for the immunological control of infection. PloS one 20120101
Immunological and nonimmunological effects of indoleamine 2,3-dioxygenase on breast tumor growth and spontaneous metastasis formation. Clinical & developmental immunology 20120101
Amelioration of 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice by immunoregulatory dendritic cells. Journal of gastroenterology 20111201
Indoleamine 2,3-dioxygenase expression in human cancers: clinical and immunologic perspectives. Clinical cancer research : an official journal of the American Association for Cancer Research 20111115
Structure-activity relationship and enzyme kinetic studies on 4-aryl-1H-1,2,3-triazoles as indoleamine 2,3-dioxygenase (IDO) inhibitors. European journal of medicinal chemistry 20111101
The role of indoleamine 2, 3-dioxygenase in lepromatous leprosy immunosuppression. Clinical and experimental immunology 20110801
Contribution of dehydroepiandrosterone sulfate and progesterone to in vitro regulation of tolerogenic activity of IFN-α-induced dendritic cells. Bulletin of experimental biology and medicine 20110601
Structure and reaction mechanism in the heme dioxygenases. Biochemistry 20110412
Expression of indoleamine 2,3-dioxygenase in acute myeloid leukemia and the effect of its inhibition on cultured leukemia blast cells. Medical oncology (Northwood, London, England) 20110301
A biological pathway linking inflammation and depression: activation of indoleamine 2,3-dioxygenase. Neuropsychiatric disease and treatment 20110101
Peripheral anti-inflammatory effects explain the ginsenosides paradox between poor brain distribution and anti-depression efficacy. Journal of neuroinflammation 20110101
Cnidarians as a source of new marine bioactive compounds--an overview of the last decade and future steps for bioprospecting. Marine drugs 20110101
Suppression of humoral immune response to hepatitis B surface antigen vaccine in BALB/c mice by 1-methyl-tryptophan co-administration. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20110101
Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells. Haematologica 20101201
Novel 1-alkyl-tryptophan derivatives downregulate IDO1 and IDO2 mRNA expression induced by interferon-gamma in dendritic cells. Molecular and cellular biochemistry 20100901
Induction of indoleamine 2,3-dioxygenase by interferon-gamma in human lens epithelial cells: apoptosis through the formation of 3-hydroxykynurenine. The international journal of biochemistry & cell biology 20100901
A combination of the metabolic enzyme inhibitor APO866 and the immune adjuvant L-1-methyl tryptophan induces additive antitumor activity. Experimental biology and medicine (Maywood, N.J.) 20100701
The role of indoleamine 2,3-dioxygenase in retinal pigment epithelial cell-mediated immune modulation. Ocular immunology and inflammation 20100101
Discrepancy between the in vitro and in vivo effects of murine mesenchymal stem cells on T-cell proliferation and collagen-induced arthritis. Arthritis research & therapy 20100101
Role of 4-1BB receptor in the control played by CD8(+) T cells on IFN-gamma production by Mycobacterium tuberculosis antigen-specific CD4(+) T Cells. PloS one 20100101
Divergent modulation of Chlamydia pneumoniae infection cycle in human monocytic and endothelial cells by iron, tryptophan availability and interferon gamma. Immunobiology 20100101
Psychological stress-induced, IDO1-dependent tryptophan catabolism: implications on immunosuppression in mice and humans. PloS one 20100101
Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis. Arthritis research & therapy 20100101
Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma. Gynecologic oncology 20091101
IDO and outcomes in ovarian cancer. Gynecologic oncology 20091101
Neuronal damage and protection in the pathophysiology and treatment of psychiatric illness: stress and depression. Dialogues in clinical neuroscience 20090901
Efficacy of levo-1-methyl tryptophan and dextro-1-methyl tryptophan in reversing indoleamine-2,3-dioxygenase-mediated arrest of T-cell proliferation in human epithelial ovarian cancer. Cancer research 20090701
Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10. Experimental & molecular medicine 20090531
Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Molecular psychiatry 20090501
Allostimulatory activity of bone marrow-derived plasmacytoid dendritic cells is independent of indoleamine dioxygenase but regulated by inducible costimulator ligand expression. Human immunology 20090501
Indoleamine 2,3 dioxygenase-mediated tryptophan catabolism regulates accumulation of Th1/Th17 cells in the joint in collagen-induced arthritis. Arthritis and rheumatism 20090501
Induction of IDO by bacille Calmette-Guérin is responsible for development of murine depressive-like behavior. Journal of immunology (Baltimore, Md. : 1950) 20090301
Substrate promiscuity of the cyclic dipeptide prenyltransferases from Aspergillus fumigatus ( section sign). Journal of natural products 20090101
Kynurenine pathway metabolites in humans: disease and healthy States. International journal of tryptophan research : IJTR 20090101
Interaction of tryptophan derivatives with SLC6A14 (ATB0,+) reveals the potential of the transporter as a drug target for cancer chemotherapy. The Biochemical journal 20080915
Synthesis of indoleamine 2,3-dioxygenase inhibitory analogues of the sponge alkaloid exiguamine A. Journal of medicinal chemistry 20080508
Indoleamine 2,3-dioxygenase-dependent tryptophan metabolites contribute to tolerance induction during allergen immunotherapy in a mouse model. The Journal of allergy and clinical immunology 20080401
Antimicrobial and immunoregulatory effects mediated by human lung cells: role of IFN-gamma-induced tryptophan degradation. FEMS immunology and medical microbiology 20080301
Levo- but not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cells. Blood 20080215
Increased striatal serotonin synthesis following cortical resection in children with intractable epilepsy. Epilepsy research 20080201
Uveal melanoma expression of indoleamine 2,3-deoxygenase: establishment of an immune privileged environment by tryptophan depletion. Experimental eye research 20071101
Effect of Kidney-replenishing herb on the indoleamine 2,3-dioxygenase of human syncytiotrophoblasts cultured in vitro and the balance of helper T-cell cytokines. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20071101
Nitric oxide and indoleamine 2,3-dioxygenase mediate CTLA4Ig-induced survival in heart allografts in rats. Transplantation 20071027
The blockade of T-cell co-stimulation as a therapeutic stratagem for immunosuppression: Focus on belatacept. Biologics : targets & therapy 20070901
Indoleamine 2, 3-dioxygenase expression in cells of human acute monocyte leukemia (M(5)) and acute lymphocyte leukemia and therapeutic effect of its inhibitor 1-methyl tryptophan. Zhongguo shi yan xue ye xue za zhi 20070601
IL-8 and IDO expression by human gingival fibroblasts via TLRs. Journal of immunology (Baltimore, Md. : 1950) 20070115
Indoleamine 2,3-dioxygenase (IDO) is involved in promoting the development of anterior chamber-associated immune deviation. Immunology letters 20061115
Hydrophobic effect and hydrogen bonds account for the improved activity of a complement inhibitor, compstatin. Journal of medicinal chemistry 20060727
Inhibition of histidine ammonia lyase by heteroaryl-alanines and acrylates. Chemistry & biodiversity 20060501
Influenza-induced expression of indoleamine 2,3-dioxygenase enhances interleukin-10 production and bacterial outgrowth during secondary pneumococcal pneumonia. The Journal of infectious diseases 20060115
CD8 alpha+, but not CD8 alpha-, dendritic cells tolerize Th2 responses via contact-dependent and -independent mechanisms, and reverse airway hyperresponsiveness, Th2, and eosinophil responses in a mouse model of asthma. Journal of immunology (Baltimore, Md. : 1950) 20050801
Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. Nature medicine 20050301
Interferon-gamma-modified dendritic cells suppress B cell function and ameliorate the development of experimental autoimmune myasthenia gravis. Clinical and experimental immunology 20041101
4-1BB-mediated immunotherapy of rheumatoid arthritis. Nature medicine 20041001
Indoleamine 2,3-dioxygenase activity and L-tryptophan transport in human breast cancer cells. Biochimica et biophysica acta 20040210
Inhibition of indoleamine 2,3-dioxygenase suppresses NK cell activity and accelerates tumor growth. Journal of experimental therapeutics & oncology 20030101
IDO (indolamine 2,3-dioxygenase) expression and function in the CNS. Advances in experimental medicine and biology 20030101
Reproducing tna operon regulation in vitro in an S-30 system. Tryptophan induction inhibits cleavage of TnaC peptidyl-tRNA. The Journal of biological chemistry 20010119
1-Methyl-DL-tryptophan, beta-(3-benzofuranyl)-DL-alanine (the oxygen analog of tryptophan), and beta-[3-benzo(b)thienyl]-DL-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase. Archives of biochemistry and biophysics 19911201
Properties